Assessment of Post-transplantation Liver Function Tests in Patients Undergoing Allogeneic Stem Cell Transplantation

被引:0
|
作者
Kiziltepe, Melih [1 ]
Yildizhan, Esra [2 ]
Unal, Ali [3 ]
Cetin, Mustafa [3 ]
Eser, Bulent [3 ]
Kaynar, Leylagul [3 ]
机构
[1] Kayseri City Hosp, Dept Internal Med, Kayseri, Turkey
[2] Kayseri City Hosp, Dept Hematol, Kayseri, Turkey
[3] Erciyes Univ, Dept Hematol, Fac Med, Kayseri, Turkey
关键词
Hematopoietic stem cell transplantation; liver function tests; hepatic dysfunction; VERSUS-HOST-DISEASE; HEPATIC VENOOCCLUSIVE DISEASE; MARROW-TRANSPLANTATION; SURVIVAL; BLOOD; RECIPIENTS; MORTALITY; TOXICITY; RELAPSE; IMPACT;
D O I
10.14744/etd.2019.26986
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Allogeneic hematopoietic stem cell transplantation is a treatment with a considerable rate of complete cure in hematological disorders. Hepatic complications are common causes of morbidity and mortality affecting the survival after stem cell transplantation. This study was conducted to identify risk factors for hepatic dysfunction and related potential factors affecting the survival in patients undergoing allogeneic hematopoietic stem cell transplantation. Materials and Methods: We retrospectively evaluated the data from 300 allogeneic hematopoietic stem cell transplantation recipients between March 2004 and May 2014 in the Erciyes University Hematology and Bone Marrow Transplantation Center, Turkey. The study included 300 patients and their serial monitorization of the liver function tests, examined before and after transplantation. Results: The transplantation in 30 patients was performed from haploidentical donors and in 13 patients from unrelated donors. We identified the liver function abnormalities in 71.7% of patients in the post-transplantation period. The most common causes were graft-versus-host disease (43.6%), drug toxicity (24.7%), and sepsis (13.9%). Post-transplantation liver abnormalities were more common in patients with acute leukemia (p=0.02), iron overload (p<0.001), and in those who also had transaminitis in the pretransplantation period (p<0.001). Relapsed underlying disease (p<0.001), iron overload, and a bilirubin level >2 mg/dL in association with hepatic dysfunction during the post-transplantation period were identified as major factors influencing mortality following transplantation (p<0.001). Conclusion: We concluded that liver function abnormalities are frequent in the hematopoietic stem cell transplantation process. For a successful management, it is important to monitor the liver function and to identify additional risk factors before and after transplantation.
引用
收藏
页码:60 / 65
页数:6
相关论文
共 50 条
  • [1] FEASIBILITY AND EFFICACY OF PARTIAL OR COMPLETE REPLACEMENT OF POST-TRANSPLANTATION CYCLOPHOSPHAMIDE WITH BENDAMUSTINE IN PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION
    Kathrotiya, Manthan
    Jitani, Ankit
    Menghani, Hemant
    Shirure, Vijay
    Bhise, Shruti
    Mundhe, Mayur
    Kazi, Wajid
    Kheni, Sandip
    Patel, Jayani
    Nair, Velu
    [J]. BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 319 - 320
  • [2] Bacterial Bloodstream Infections in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
    Salas, Maria Queralt
    Charry, Paola
    Puerta-Alcalde, Pedro
    Martinez-Cibrian, Nuria
    Solano, Maria Teresa
    Serrahima, Ana
    Nomdedeu, Meritxell
    Cid, Joan
    Lozano, Miquel
    Chumbinta, Mariana
    Aiello, Tommaso Francesco
    Arcarons, Jordi
    de LLobet, Noemi
    Pedraza, Alexandra
    Rosinol, Laura
    Esteve, Jordi
    Urbano-Ispizua, Alvaro
    Carreras, Enric
    Martinez, Carmen
    Fernandez-Aviles, Francesc
    Garcia-Vidal, Carolina
    Suarez-Lledo, Maria
    Rovira, Monserrat
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (12): : 850.e1 - 850.e10
  • [3] Zinc Deficiency In Patients Adults Undergoing To Hematopoietic Stem Cell Post-Transplantation
    Pereira, Andrea Z.
    Juliana, Silva Bernardo
    Pivocari, Silvia M. F.
    Tanaka, Marcia
    Paula, Barrere N. Ana
    Lucio, Fabiana
    Castro, Claudio Galvao, Jr.
    Ribeiro, Andreza Alice Feitosa
    Hamerschlak, Nelson
    [J]. BLOOD, 2013, 122 (21)
  • [4] Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis
    Tania Jain
    Katie L. Kunze
    Luke Mountjoy
    Daniel K. Partain
    Heidi Kosiorek
    Nandita Khera
    William J. Hogan
    Vivek Roy
    James L. Slack
    Pierre Noel
    Veena D. S. Fauble
    Jose F. Leis
    Lisa Sproat
    Ayalew Tefferi
    Mrinal M. Patnaik
    Ruben A. Mesa
    Jeanne Palmer
    [J]. Blood Cancer Journal, 10
  • [5] Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis
    Jain, Tania
    Kunze, Katie L.
    Mountjoy, Luke
    Partain, Daniel K.
    Kosiorek, Heidi
    Khera, Nandita
    Hogan, William J.
    Roy, Vivek
    Slack, James L.
    Noel, Pierre
    Fauble, Veena D. S.
    Leis, Jose F.
    Sproat, Lisa
    Tefferi, Ayalew
    Patnaik, Mrinal M.
    Mesa, Ruben A.
    Palmer, Jeanne
    [J]. BLOOD CANCER JOURNAL, 2020, 10 (03)
  • [6] Allogeneic hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for patients with inherited non-malignant diseases
    Borovkova, A.
    Bykova, T.
    Paina, O.
    Kozhokar, P.
    Slesarchuk, O.
    Osipova, A.
    Muhinova, A.
    Babenko, E.
    Barhatov, I.
    Ekushov, K.
    Averyanova, M.
    Alyanskiy, A.
    Semenova, E.
    Zubarovskaya, L.
    Afanasyev, B.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S430 - S431
  • [7] Physiotherapy in patients undergoing allogeneic stem cell transplantation
    Rejskova, K
    Maalouf, J
    Cetkovsky, P
    [J]. BONE MARROW TRANSPLANTATION, 2005, 35 : S298 - S298
  • [8] Cognitive function in patients prior to undergoing allogeneic hematopoietic stem cell transplantation
    Zev M. Nakamura
    Allison M. Deal
    Donald L. Rosenstein
    Laura J. Quillen
    Stephanie A. Chien
    William A. Wood
    Thomas C. Shea
    Eliza M. Park
    [J]. Supportive Care in Cancer, 2021, 29 : 2007 - 2014
  • [9] Cognitive function in patients prior to undergoing allogeneic hematopoietic stem cell transplantation
    Nakamura, Zev M.
    Deal, Allison M.
    Rosenstein, Donald L.
    Quillen, Laura J.
    Chien, Stephanie A.
    Wood, William A.
    Shea, Thomas C.
    Park, Eliza M.
    [J]. SUPPORTIVE CARE IN CANCER, 2021, 29 (04) : 2007 - 2014
  • [10] Reconstitution of Memory T -Cells after Allogeneic Stem Cell Transplantation in Patients with Post-Transplantation Cyclophosphamide As Tolerance Induction
    Vasilyeva, Vera
    Parovichnikova, Elena N.
    Kuzmina, Larisa A.
    Drokov, Mikhail
    Mikhaltsova, Ekaterina
    Koroleva, Olga
    Dubnyak, Daria
    Galtseva, Irina
    Savchenko, Valeri G.
    [J]. BLOOD, 2015, 126 (23)